Relay Therapeutics (RLAY)
(Real Time Quote from BATS)
$7.70 USD
-0.29 (-3.63%)
Updated Aug 2, 2024 10:16 AM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/6/24 |
---|---|
Current Quarter | -0.72 |
EPS Last Quarter | -0.62 |
Last EPS Surprise | 11.43% |
ABR | 1.17 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.81 |
Next Year | -2.81 |
EPS (TTM) | -2.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.35M | 0.35M | 10.45M | 3.45M |
# of Estimates | 2 | 2 | 5 | 2 |
High Estimate | 0.50M | 0.50M | 11.51M | 6.10M |
Low Estimate | 0.20M | 0.20M | 10.00M | 0.80M |
Year ago Sales | 0.12M | 25.20M | 25.55M | 10.45M |
Year over Year Growth Est. | 191.67% | -98.61% | -59.11% | -66.97% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.72 | -0.73 | -2.81 | -2.81 |
# of Estimates | 8 | 7 | 9 | 9 |
Most Recent Consensus | -0.72 | -0.74 | -2.80 | -2.65 |
High Estimate | -0.64 | -0.71 | -2.67 | -2.43 |
Low Estimate | -0.75 | -0.79 | -3.03 | -3.12 |
Year ago EPS | -0.81 | -0.54 | -2.79 | -2.81 |
Year over Year Growth Est. | 11.11% | -35.19% | -0.72% | -0.04% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.72 | -0.73 | -2.81 | -2.81 |
7 Days Ago | -0.72 | -0.73 | -2.81 | -2.81 |
30 Days Ago | -0.72 | -0.73 | -2.81 | -2.82 |
60 Days Ago | -0.72 | -0.73 | -2.83 | -2.78 |
90 Days Ago | -0.70 | -0.71 | -2.82 | -2.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.72 | -0.74 | -2.80 | -2.65 |
Zacks Consensus Estimate | -0.72 | -0.73 | -2.81 | -2.81 |
Earnings ESP | 0.00% | -0.78% | 0.43% | 5.81% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.62 | -0.67 | -0.54 | -0.81 | NA |
Estimate | -0.70 | -0.76 | -0.83 | -0.78 | NA |
Difference | 0.08 | 0.09 | 0.29 | -0.03 | 0.11 |
Surprise | 11.43% | 11.84% | 34.94% | -3.85% | 13.59% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more